KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Asset Utilization Ratio (2018 - 2025)

Bionano Genomics' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.37 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 20.41% year-over-year to 0.37; the TTM value through Sep 2025 reached 0.37, up 20.41%, while the annual FY2024 figure was 0.21, 52.79% up from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.37 at Bionano Genomics, up from 0.36 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.38 in Q4 2024 and bottomed at 0.04 in Q2 2021.
  • The 5-year median for Asset Utilization Ratio is 0.11 (2023), against an average of 0.17.
  • The largest annual shift saw Asset Utilization Ratio crashed 90.21% in 2021 before it surged 127.63% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.05 in 2021, then surged by 80.48% to 0.09 in 2022, then surged by 106.9% to 0.18 in 2023, then skyrocketed by 105.88% to 0.38 in 2024, then fell by 1.29% to 0.37 in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Asset Utilization Ratio are 0.37 (Q3 2025), 0.36 (Q2 2025), and 0.37 (Q1 2025).